X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB DR. REDDYS LAB UNICHEM LAB/
DR. REDDYS LAB
 
P/E (TTM) x -273.6 40.9 - View Chart
P/BV x 2.0 3.1 64.4% View Chart
Dividend Yield % 1.3 0.9 146.9%  

Financials

 UNICHEM LAB   DR. REDDYS LAB
EQUITY SHARE DATA
    UNICHEM LAB
Mar-17
DR. REDDYS LAB
Mar-17
UNICHEM LAB/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3203,397 9.4%   
Low Rs2212,560 8.6%   
Sales per share (Unadj.) Rs167.2856.5 19.5%  
Earnings per share (Unadj.) Rs12.078.0 15.3%  
Cash flow per share (Unadj.) Rs16.9139.9 12.1%  
Dividends per share (Unadj.) Rs3.0020.00 15.0%  
Dividend yield (eoy) %1.10.7 165.2%  
Book value per share (Unadj.) Rs117.0739.8 15.8%  
Shares outstanding (eoy) m90.88165.74 54.8%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x1.63.5 46.5%   
Avg P/E ratio x22.638.2 59.2%  
P/CF ratio (eoy) x16.021.3 75.0%  
Price / Book Value ratio x2.34.0 57.4%  
Dividend payout %25.125.7 97.8%   
Avg Mkt Cap Rs m24,578493,632 5.0%   
No. of employees `0005.222.7 22.9%   
Total wages/salary Rs m2,48731,068 8.0%   
Avg. sales/employee Rs Th2,928.36,259.0 46.8%   
Avg. wages/employee Rs Th479.41,369.8 35.0%   
Avg. net profit/employee Rs Th209.4569.7 36.8%   
INCOME DATA
Net Sales Rs m15,195141,961 10.7%  
Other income Rs m1101,715 6.4%   
Total revenues Rs m15,305143,676 10.7%   
Gross profit Rs m1,78824,722 7.2%  
Depreciation Rs m45210,266 4.4%   
Interest Rs m34634 5.3%   
Profit before tax Rs m1,41315,537 9.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m0349 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3262,965 11.0%   
Profit after tax Rs m1,08712,921 8.4%  
Gross profit margin %11.817.4 67.6%  
Effective tax rate %23.119.1 120.9%   
Net profit margin %7.29.1 78.6%  
BALANCE SHEET DATA
Current assets Rs m6,42696,837 6.6%   
Current liabilities Rs m3,91784,199 4.7%   
Net working cap to sales %16.58.9 185.5%  
Current ratio x1.61.2 142.6%  
Inventory Days Days6873 92.3%  
Debtors Days Days7798 78.8%  
Net fixed assets Rs m7,410102,552 7.2%   
Share capital Rs m182829 21.9%   
"Free" reserves Rs m10,454121,792 8.6%   
Net worth Rs m10,636122,621 8.7%   
Long term debt Rs m45,449 0.1%   
Total assets Rs m15,258218,165 7.0%  
Interest coverage x42.925.5 168.3%   
Debt to equity ratio x00 0.9%  
Sales to assets ratio x1.00.7 153.1%   
Return on assets %7.36.2 118.2%  
Return on equity %10.210.5 97.0%  
Return on capital %13.612.9 105.4%  
Exports to sales %24.154.6 44.2%   
Imports to sales %4.99.4 52.9%   
Exports (fob) Rs m3,66677,520 4.7%   
Imports (cif) Rs m75213,274 5.7%   
Fx inflow Rs m5,29881,670 6.5%   
Fx outflow Rs m026,355 0.0%   
Net fx Rs m5,29855,315 9.6%   
CASH FLOW
From Operations Rs m68321,444 3.2%  
From Investments Rs m-1,316-18,404 7.1%  
From Financial Activity Rs m592-3,692 -16.0%  
Net Cashflow Rs m-40-1,144 3.5%  

Share Holding

Indian Promoters % 50.1 25.5 196.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 5.4 279.6%  
FIIs % 3.0 35.3 8.5%  
ADR/GDR % 0.0 18.5 -  
Free float % 31.7 15.3 207.2%  
Shareholders   20,176 75,885 26.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   PANACEA BIOTECH  DISHMAN PHARMA  TTK HEALTHCARE  NATCO PHARMA  DIVIS LABORATORIES  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Metal Stocks Drag(09:30 am)

Asian share markets slipped in the opening trade today as investors digested the escalation in trade tensions between the US and China after both countries announced tariffs last week.

Related Views on News

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jun 18, 2018 11:33 AM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS